好利來(002729.SZ):好利來控股及旭昇投資提前終止減持計劃 合計減持1%股份
格隆匯 7 月 6日丨好利來(002729.SZ)公佈,公司於今日收到好利來控股有限公司(“好利來控股”)及旭昇亞洲投資有限公司(“旭昇投資”)的書面告知函,好利來控股及旭昇投資於2020年6月24日至2020年7月3日期間通過集中競價交易方式合計減持其所持公司股份66.6712萬股,佔公司總股本的1.00%,並於2020年7月6日提前終止前述減持計劃。好利來控股及旭昇投資連續六個月內通過證券交易系統出售的股份低於公司股份總數的5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.